2[12]Listi F,Candore G,Lio D,et al.Association between platelet endothelial cellular adhesion molecule 1(PECAM-1/CD31)polymorphisms and acute myocardial infarction:a study in patients from Sicily.Eur J Immunogenet,2004,31:175-178.
3[13]Blankenberg S,Rupprecht HJ,Bickel C,et al.Circulating cell adhesion molecules and death in patients with coronary artery disease.Circulation,2001,104:1336-1342.
4[14]Soeki T,Tamura Y,Shinohara H,et al.Increased soluble platelet/endothelial cell adhesion molecule-1 in the early stage of acute coronary syndromes.Int J Cardiol,2003,90:261-268.
5[15]Kharea A,Shettya S,Ghosha K,et al.Valuation of markers of endothelial damage in cases of young myocardial infarction.Atherosclerosis,2005,180:375-380.
6[16]Behar E,Chao N,Hiraki D,et al.Polymorphism of adhesion molecule CD31 and its role in acute graftversus-host disease.Engl J Med,1996,334:286-291.
7[19]Falati S,Patil S,Gross PL,et al.Platelet PECAM-1inhibits thrombus formation in vivo.Blood,2006,107:535-541.
8[20]Victor S,Paul G.Effect of thrombolytic therapy on platelet expression and plasma concentration of PECAM-1(CD31)in patients with acute myocardial infarction.Arterioscler Thromb Vase Biol,1999,19:153-158.
9[22]Eleftherios X,Scott S,Michael F.Nitric oxide mediates the effect of fluvastatin on intercellular adhesion molecule-1 and platelet endothelial cell adhesion molecule-1 expression on human endothelial cells.Ann Vascu Surg,2005,19:386-392.
10[23]Berg A,Schmidt A,Baumstark W,et al.Lipoprotein phenotype and adhesion molecules correlate with diurnal triglyceride profiles in patients with coronary artery disease.Nutr Metab Cardiovase Dis,2004,14:20-25.
